Sosten CG iny.
Laboratorio:
Mayors
$57.72
Out of stock
USD
/ unidad
El presupuesto final se adapta según el volumen solicitado y el destino de entrega.
- Distribución oficial habilitada por SENASA Establecimiento oficial y normativas sanitarias vigentes
- Cadena de frío garantizada Monitoreo térmico para biológicos y sueros
- Dirección técnica y asesoramiento veterinario Atención profesional especializada en medicina equina
- Envíos nacionales e internacionales especializados Acondicionamiento térmico y logística segura
Sosten CG iny.
$57.72
USD
Out of stock
CG EQUINE SUPPORT; Osteoarticular regenerator, chondrogenesis promoter, and anti-arthritic agent; Chondroitin Sulfate/Glucosamine Sulfate for injection; Chondroitin sulfate and glucosamine are the drugs of choice because they are capable of sustaining or promoting the metabolic activity of chondrocytes while simultaneously inhibiting the degradative action of mediators (cytokines or prostaglandins) or enzymes (proteases) on articular cartilage. These drugs control inflammation and the biosynthesis of macromolecules in other connective tissues such as synovial membranes, ligaments, and tendons; OSTEOARTICULAR REGENERATOR, CHONDROGENESIS PROMOTER, AND ANTI-ARTHROSIS AGENT; FOR SUBCUTANEOUS OR INTRAMUSCULAR INJECTION; Presentation: Each box contains 5 vials with 5 mL of injectable solution; INDICATIONS:; Physiological treatment of cartilage; Adjuvant in the treatment of generalized or localized osteoarthritis, degenerative osteoarticular pathology (osteoarthrosis); Remodeling of structures deformed by osteodystrophic processes during growth and development; Non-infectious synovitis, ligament injuries; Repair processes of ligaments and tendons, as well as bone and cartilage fractures; Protects cartilage and increases resistance to stress during periods of increased joint strain—such as training and competitions. - Natural analgesic; DOSAGE; 5 ml as the average dose for animals weighing 400 kg; One application every 5 days; In acute cases: one dose daily for 8 days, followed by administration every 5 days until symptoms subside, for approximately 60 days; The duration of treatment depends on the severity of osteoarthritis, the intensity of factors contributing to secondary osteoarthritis, and the individual’s response
Laboratory
Mayors